Manufacture of 14C-Labelled Antibody Drug Conjugate
2016년 07월 05일
The approach taken for a client who trusted Almac for the manufacture and supply of 14C-labelled antibody drug conjugate for ...
x
IMPORTANT MESSAGE
Like many other companies and institutions around the world, we are experiencing interference with some of our systems within the TNT network.
We are implementing remediation steps as quickly as possible. We have implemented operational contingencies to continue to complete collections from customers with scheduled stops. For customers who do not have a regular stop, collection should be arranged via our customer service centers.
Customers may experience delays in the transit of shipments, particularly inter-continental or non-EU European delivery, as we work to remediate our systems. Additionally, if customers do not have the facility for self-labeling, they may also experience delays.
We are not able to collect shipments of dangerous goods at this time.
We regret any inconvenience to our customers.
Case Studies
Requirement for Synthesis of Non-GMP 14C API
2016년 07월 05일
The approach taken for a client who trusted Almac for the supply of non-GMP 14C API for their drug development ...
An HPLC-MS/MS Method for the Determination of Oxycodone, Noroxycodone & Oxymorphone in Human Plasma
2016년 06월 29일
Oxycodone, an opiod analgesic that closely resembles morphine, is often used for the control of pain in cancer and organ ...
Determination of Isotopic Purity by Accurate Mass LC/MS
2016년 06월 29일
Following the synthesis of isotopic labelled APIs at Almac, or stability testing, it is often necessary to accurately determine the ...
Trace Impurity Identification using Q-TOF Mass Spectroscopy
2016년 06월 27일
Accurate Mass Spectrometry (MS) techniques are ideally suited to aid in the structural elucidation of trace impurities.
Large Pharma Company Utilises Almac's Excursion Management Solution To Meet New GDP Regulations
2016년 06월 24일
As a result of updated GDP’s regulations, a large pharmaceutical company started including temperature monitors into a large percentage of ...
Small Biotech Company Running a Phase II Study With Limited Drug Availability
2016년 06월 22일
Small biotech company running a Phase II study with limited drug availability at study start-up, supplements its internal resource with ...
Case Study: Integrated Multi-Site Commercial Product Transfer
2016년 05월 05일
Strategic Capital Investment
2015년 11월 25일
To learn how one of our clients, Ironwood Pharmaceuticals, benefited from a significant capital investment and facility modification to support ...
Major Pharma Company Implements FDA Recommendations
2015년 10월 06일
During a recent FDA clinical inspection of a major pharmaceutical company, the auditor placed a strong focus on temperature excursion ...
Meeting Regulatory Requirements in Japan: Customised IXRS® Manages Patient-Specific Drug Orders
2015년 03월 04일
Filling patient-specific drug orders requires thinking beyond an organisation’s standard supply chain processes.
Clinical Supply Chain Management - Top CRO - 3 x Phase II Studies
2015년 03월 04일
Almac's Supply Chain Management team oversight, helps a TopCRO client optimise the drug supply for a study sponsor based in ...
Clinical Supply Chain Management - Large Biotech - Phase III Study
2015년 02월 25일
A large biotech client approached Almac for its Supply Chain Management expertise to optimise the drug supply strategy for a ...
Clinical Supply Chain Management: Biotech - Phase III Study
2015년 02월 25일
A small Biotech company running a pivotal phase III study employed the expertise of Almac's Supply Chain Management team to ...
Clinical Supply Chain Management - Global Pharma - Phase III
2015년 02월 25일
Our client, one of the top 20 global, pharmaceutical companies was conducting a phase III trial to compare the efficacy, ...
Supplying Costly Investigational Product: Pre-Randomisation Approach Reduces Drug Wastage
2015년 02월 25일
Certainly, every sponsor wants to minimize wastage in clinical trial supplies, but the motivation to do so is extraordinary when ...
A Competitive Race: Accelerating The Development Timeline with a Multi-Trial IRT Program
2015년 02월 25일
Time is always of the essence in clinical trials. But when competitors have the lead in bringing an alternative therapy ...
The Effect of Crystal Orientation on Raman Spectra
2015년 02월 25일
Here we show data highlighting the large spectral differences that can arise between the Raman spectra collected with different orientation ...
Key Strategies Central to Overcoming Poor API Solubility
2015년 02월 25일
Noel Hamill, an Investigator with the Physical Sciences Group at Almac discusses various fit for purpose and cost effective routes ...
Fluorescence Lifetime Assays
2015년 02월 25일
Luminescence and fluorescence based assay methods prevail in modern HTS. Although invaluable as technologies, the problem of compound-related assay interferences ...
API Manufacturers Stay Ahead of The Game
2015년 02월 25일
Pharmaceutical companies are increasingly enlisting the help of API contract manufacturers to improve efficiencies. But as the field becomes more ...
Development of a Novel Blinding Methodology for a Market Leading DPI
2015년 02월 20일
While Almac has already developed and validated blinding techniques for most leading inhalers, continued launches of new inhalers mean we ...
@AlmacGroup on Twitter
- The Almac Belfast City Women's 10K has officially sold out! To celebrate, we are excited to unveil the 2023 medal… https://t.co/lnWu3qdtSm
- Join us in Audubon, PA on June 13th for our open house, where you will get the opportunity to tour our state-of-the… https://t.co/P06GhLCxYh
- Sign-up today at https://t.co/3JI1IbonuZ and join us for the Almac Belfast City Women’s 10K on Sunday 18th June! https://t.co/MJ5KhEdxuF